ATC Group: L01XY Combinations of antineoplastic agents
The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical
composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the
pharmaceutical industry.
Liposomal formulation of a fixed combination of daunorubicin and cytarabine in a 1:5 molar ratio. The 1:5 molar ratio has been shown in vitro and in vivo to maximise synergistic antitumour activity in acute myeloid leukaemia (AML).
